Blake Wise
Director at Calithera Biosciences, Inc. (CALA)
Blake Wise has filed 2 insider reports with the SEC since June 2021, as director at Calithera Biosciences, Inc. (CALA). The latest filing, on June 3, 2022, reports grant or award at Calithera Biosciences, Inc. (CALA).
- Filings
- 2
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Blake Wise is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | Jun 3, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 1, 2022CALASEC Form 4 filed by Wise BlakeForm 4Grant or award
- Jun 11, 2021CALASEC Form 4 filed by Wise BlakeForm 4Grant or award
Compare Blake Wise with
- Blake Wise vs Deepika Pakianathan1 shared
- Blake Wise vs Eric Sjogren1 shared
- Blake Wise vs Emil Kuriakose1 shared
- Blake Wise vs Susan Molineaux1 shared
- Blake Wise vs Stephanie Wong1 shared
- Blake Wise vs Christopher Molineaux1 shared
Questions about Blake Wise
- What is Blake Wise's role at Calithera Biosciences, Inc.?
- Blake Wise reports to the SEC as director at Calithera Biosciences, Inc. (CALA), according to the latest filing on June 3, 2022.
- Has Blake Wise bought or sold stock recently?
- No open-market purchases or sales by Blake Wise are on file. The filings report grant or award.
- How do I get alerts when Blake Wise files?
- Follow Blake Wise on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Blake Wise (SEC CIK 0001654446). Totals count each trade once, skipping amendments whose original is on file, from Jun 14, 2021 on. View on SEC EDGAR